The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

Samaritan Medical Center has announced that its Pain Management Center will close its door at the end of next month. In an ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

新泽西州罗斯兰 - 市值1.01亿美元的先进药物输送仪器开发商Milestone Scientific Inc. (NYSE: MLSS)宣布在领先的疼痛管理诊所Advanced Spine and Pain Management商业推出其CompuFlo®硬膜外麻醉系统。这一进展是在与Varinder ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...